SCHEMBL2802608

SCHEMBL2802608

CCCCCCCCCCC(O)c1ccc(OC)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.56
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
PPARG P37231 1/20 0.51
PPARD Q03181 1/20 0.51
PPARA Q07869 1/20 0.51
HTR1A P08908 1/20 0.48
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 2/20 0.46
TOP1 P11387 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
HIF1A Q16665 1/20 0.45
EPAS1 Q99814 1/20 0.45
EPHX2 P34913 1/20 0.45
ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6055199 0.93 PDE4D (0.62) PDE4DPDE4APDE4BPDE4CPPARG
SCHEMBL5492854 0.88 PDE4D (0.64) PDE4DPDE4APDE4BPDE4CPPARG
SCHEMBL15194927 0.86 PDE4D (0.47) PDE4DPDE4APDE4BPDE4CHTR1A
SCHEMBL10335590 0.86 PPARG (0.61) PDE4DPDE4APDE4BPDE4CPPARG
SCHEMBL28550136 0.86 CYP3A4 (0.67) HTR1ACYP3A4TSHRNFKB1BLM
SCHEMBL27107627 0.84 NR1I2 (0.50) PDE4DPPARGPPARDPPARAHTR1A
SCHEMBL27570423 0.83 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CPPARG
SCHEMBL6055371 0.83 PPARG (0.61) PDE4DPDE4APDE4BPDE4CPPARG
SCHEMBL12898700 0.83 SLC2A1 (0.54) PPARGPPARDPPARAHTR1AEPHX2
SCHEMBL7465208 0.83 PPARG (0.43) PDE4DPPARGPPARDPPARAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12060538-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2024-08-13 US disclosed
US-20230183603-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION 2023-06-15 US disclosed
US-11624041-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2023-04-11 US disclosed
US-20200263110-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION 2020-08-20 US disclosed
US-10626349-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2020-04-21 US disclosed
US-20180187127-A1 CLEAVABLE SURFACTANTS JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2018-07-05 US disclosed
US-9816054-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2017-11-14 US disclosed
EP-2584027-B1 Cleavable surfactants PROMEGA CORP (US) 2015-12-30 EP disclosed
EP-2584027-A2 Cleavable surfactants Promega Corporation (US) 2013-04-24 EP disclosed
EP-2197996-B1 CLEAVABLE SURFACTANTS PROMEGA CORP (US) 2012-12-05 EP disclosed
EP-2197996-A2 CLEAVABLE SURFACTANTS Promega Corporation (US) 2010-06-23 EP disclosed
WO-2009048611-A2 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 WO disclosed
US-20090095628-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200263110-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885
US-11624041-B2 Cleavable surfactants SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885
US-12060538-B2 Cleavable surfactants SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885
US-20180187127-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885
US-10626349-B2 Cleavable surfactants SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885
US-20090095628-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885
US-20230183603-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 PDE4D 3003/4885PDE4A 2726/4885PDE4B 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.